Moderna asks FDA to approve Covid-19 shot update

Modern Inc. has asked US regulators to authorize a new version of its Covid-19 vaccine that targets the latest strains of coronavirus.

Moderna said Tuesday it is ready to ship doses of the new vaccine in September if cleared by the Food and Drug Administration. Health authorities have been looking for such boosters for a campaign to strengthen people’s immune defenses during the fall and winter.